At Santen, the needs of patients—like Mark*—are inspiring ophthalmic medicine.
Our single focus in ophthalmology enables exploration of novel therapies in uveitis, glaucoma, and dry eye—therapies determined to challenge eye disease, one patient at a time.
|*||Image is designed to represent a patient. For illustrative purposes only.|
- Read about how our pipeline drugs work at the molecular level.
- We're looking for sharp, talented individuals to join our team in Emeryville, California. Explore a career with Santen today.
- Santen Phase III study meets primary endpoint for the treatment of non-infectious posterior segment uveitis (NI-PSU)